ロード中...
Sorafenib in the management of metastatic renal cell carcinoma
PURPOSE: Sorafenib represents one of the two standards of care for patients with metastatic renal cell carcinoma (mrcc). In the present review, we provide information regarding the use of sorafenib in first and second lines. We also describe results for dose escalation strategies. Finally, we provid...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Multimed Inc.
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2687798/ https://ncbi.nlm.nih.gov/pubmed/19478894 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|